REQUEST A DEMO
Total
USD $0.00
Search more companies

Biomerieux Asia Pacific Pte. Ltd. (Singapore)

Main Activities: Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers
Secondary Activities: Corporate, Subsidiary, and Regional Managing Offices
Full name: Biomerieux Asia Pacific Pte. Ltd. Profile Updated: September 30, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Primary Business Activity: wholesale of medical, professional, scientific and precision equipment (distribution hub); Secondary Business Activity: activities of head and regional head offices; centralised administrative offices and subsidiary management offices (regional head office)

Headquarters
11 Biopolis Way, #10-04 Helios, Singapore
Singapore; Singapore; Postal Code: 138667

Contact Details: Purchase the Biomerieux Asia Pacific Pte. Ltd. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Biomerieux Asia Pacific Pte. Ltd. report to view the information.
Financial Auditors:
Purchase the Biomerieux Asia Pacific Pte. Ltd. report to view the information.
Incorporation Date:
August 01, 2019
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Company Secretary
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Biomerieux Asia Pacific Pte. Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency SGD. Absolute financial data is included in the purchased report.
Net sales revenue
42.35%
Total operating revenue
42.35%
Net Profit (Loss) for the Period
84.79%
Total assets
0.94%
Total equity
192.2%
Net Profit Margin
1.28%
Return on Equity (ROE)
-38.12%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?